Primoris Companies Corporation Announces Results Of Annual Stockholders Meeting

Dovie Salais

A monetary analyst career usually includes assessing shares, bonds, and other funding performances in order to provide sound advice and particular person or portfolio suggestions to companies, buyers, and individuals. Typically, accountants and auditors need a Bachelor’s degree in Accounting or associated area, similar to inside auditing or business administration […]

Jaunt Air Mobility Announces Access Skyways to Support Integration of Advanced Air Mobility Transportation Worldwide

Dovie Salais

Jaunt Air Mobility announces Access Skyways Jaunt Air Mobility eVTOL air taxi Jaunt Air Mobility eVTOL air taxi Jaunt Air Mobility announces Access Skyways Access Skyways is focused on supporting Advanced Air Mobility operations. Access Skyways is focused on supporting Advanced Air Mobility operations. DALLAS, Oct. 23, 2020 (GLOBE NEWSWIRE) […]

Bicycle Therapeutics Announces Expansion of Scientific Advisory Board

Dovie Salais

– Four renowned experts join to advise Bicycle as the company advances pipeline of novel cancer therapeutic candidates Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that leaders in the fields of oncology, […]

Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital

Dovie Salais

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has completed its at-the-market (ATM) offering program initiated during the third quarter, generating gross proceeds of $50.0 million. […]

Bicycle Therapeutics Announces Pipeline Progress Update

Dovie Salais

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced progress updates across its wholly-owned and partnered programs in oncology and non-oncology indications. “We and our partners have recently achieved […]

Subscribe US Now